Clinical Trial Update: Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES [Phase 4]

View source ↗

Summary

Phase 4 trial update on the renal effects of combining empagliflozin and linagliptin in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Linagliptin (linagliptin)

Snippet

Sponsor: M.H.H. Kramer | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN